Cancer immunology and immunotherapy
We work on developing therapeutic cancer vaccines, immune-enhancers, checkpoint-inhibitors and other immunotherapies for different solid tumours such as breast cancer, melanoma as well as head and neck carcinoma. We utilize in our research virus-like nanoparticles (VLPs) as an efficient platform for vaccine development. Designing and developing personalised cancer vaccines are of high-interest in our research. We have provided proof-of-concepts (PoCs) for effective therapeutic cancer vaccines and immune-enhancers in different preclinical murine models. We have been awarded several funding grants to develop cancer immunotherapy.